Default company panoramic image
7c323045 6716 47e5 84bd 8deeb1a92790

dispersol technologies llc

DisperSol develops drug delivery platforms with compositions that could not be processed by other methods utilizing its patented technology

  • Stage $500K in TTM Revenue
  • Industry Healthcare Services
  • Location Georgetown, TX, USA
  • Currency USD
  • Founded August 2007
  • Employees 11
  • Website

Company Summary

DisperSol is a high growth company reformulating and manufacturing challenging existing drugs. Currently working with 3 companies delivering drugs for pre and clinical trials, planning to commercially manufacture these in its GMP facility. DisperSol is in advanced development of a tamper resistant platform for the manufacture of opioid drugs. Company has 3 issued patents and 3 patent applications. Currently expanding 3X capacity by Q4 2014


  • Default avatar
    Chris Brough, MSc, MBA
    VP, Technology

    Former VP Engineering at IntegriCo Composites. Inventor of underlying technology – 15 years experience in polymer manufacturing

  • Default avatar
    Justin Keen, BSc ChE
    VP, Operations

    Former Director of Manufacturing at PharmaForm. Over 10 years experience in pharma processing and commercial manufacturing.

  • Default avatar
    Gershon Yaniv, PhD, MBA

    Former CEO of IntegriCo Composites, experienced entrepreneur with 25 years leading high tech companies. Former Professor mechanics of materials at Northwestern.

  • Default avatar
    Dave Miller, PhD
    VP, R&D

    Dave is the former principal scientist in charge of reformulations and manufacturing for Hoffman, la Roche.

Previous Investors

  • Default avatar
    Acadia Woods Partners, NYC
    Default avatar
    Chart Venture Partners, NYC